David P. Foley

Showing 1-5 of 5 articles

Author Simon J. Walsh

Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson T, Hill J, Hussein H, Bogaerts K, Morice M, Foley DP

June 14, 2018 | 10.4244/EIJ-D-18-00346

Author Martin Bergmann

Interventions for stroke

Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study

Bergmann M, Ince H, Kische S, Schmitz T, Meincke F, Schmidt B, Foley DP, Betts TR, Grygier M, Protopopov A, Stein KM, Boersma L

April 20, 2018 | 10.4244/EIJ-D-17-00672

Author Maik J. Grundeken

Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies

Grundeken M.J, Asgedom S, Damman P, Lesiak M, Norell M, Garcia E, Bethencourt A, Woudstra P, Koch K, Vis M, Henriques J, Onuma Y, Foley DP, Bartorelli A, Stella P, Thijssen J, de Winter R, Wykrzykowska J

June 28, 2013 | 10.4244/EIJV9I2A34

Author Michael Magro

Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry

Magro M, Girasis C, Bartorelli A, Tarantini G, Russo F, Trabattoni D, D’Amico G, Galli M, Juame A, de Sousa Almeida M, Simsek C, Foley DP, Sonck J, Lesiak M, Kayaert P, Serruys P, van Geuns R

March 22, 2013 | 10.4244/EIJV8I11A194

Author Pierfrancesco Agostoni

A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry

Agostoni P, Foley DP, Lesiak M, Belkacemi A, Dens J, Kumsars I, Scott B, Oemrawsingh P, Dubois C, Garcia E, Lefèvre T, Stella P

March 21, 2012 | 10.4244/EIJV7I11A204

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years

(The Trials book is supported by Biotronik)

December 13, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke